On-Demand Webinar: Understanding How Single Cell Evolution Drives Tumor Complexity
Watch Time: 47 minutes
Overview:
The evolution of a single cellular change into oncology-related pathology is complex, driven by mutations accumulated during cell division, cell to cell interactions, and tissue structure and vasculature changes.
A challenge researchers face in obtaining high-definition genomic data from single cells is isolating critical cells of interest and amplifying their genomes with high uniformity and complete coverage.
Watch this webinar as Andris Abramenkovs of Sartorius introduces the CellCelector Flex platform. Mark Lynch of BioSkryb Genomics then presents a novel workflow that simplifies single cell isolation from a variety of samples for low-input and single cell genomics.
- Automated cell selection and retrieval to improve downstream application workflows
- Reliable single cell isolation for genomic analysis using Primary Template-Directed Amplification (PTA)
- Addressing and overcoming workflow challenges, and defining genomic heterogeneity in any sample type
Webinar Speakers
Andris Abramenkovs, PhD
Product Manager
Sarorius
Dr. Andris Abramenkovs is currently a Product Manager with Sartorius AG, having been with the company since June 2019. This comes after earning a PhD in Medical Sciences from Uppsala University in Sweden where he researched DNA damage, repair, and treatment options. He aspires to continuously develop his skills and expertise in both research & development (R&D) and scientific projects through problem solving, laboratory experiments, and scientific communication.
Mark Lynch
Senior Vice President, Global Sales and Customer Success
BioSkryb Genomics
Mark has held various commercial, applications and business development roles across numerous geographies in organizations such as Applied Biosystems, Fluidigm Corporation and most recently Genomic Vision.
Single-cell biology is an area that Mark helped to establish with key leaders in the field such as EBI-Sanger, Cambridge Institute for Molecular Medicine, CRUK, Pasteur Institute, German Cancer Center, Oxford Genomics Center, and other key customer sites across Europe.
Mark graduated from University of Glasgow, UK in 2003 with a bachelor's degree in Microbiology.
